National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI-Supported Cancer Clinical Trials: Facts and Figures
    Posted: 12/18/2000    Updated: 03/28/2006



Overview






Patients Participating in NCI Treatment Trials






Physicians Participating in NCI Clinical Trials






Costs Associated with NCI Clinical Trials






Other Organizations Sponsoring Clinical Trials






References



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
References

  1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: Race-, Sex-, and Age-Based Disparities. Journal of the American Medical Association 2004;291:2720-2726. [Abstract] Last accessed July 6, 2005.
  2. Christian MC, Trimble EL. Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials. Cancer Epidemiology, Biomarkers & Prevention 2003 (suppl.):12:277s-283s. [Abstract] Last accessed July 6, 2005.
  3. Albritton K and Bleyer WA. The management of cancer in the older adolescent. European Journal of Cancer 2003;39:2584-2599. [Abstract] Last accessed July 6, 2005.
  4. Aapro MS et al. Never too old? Age should not be a barrier to enrollment in cancer clinical trials. The Oncologist 2005;10:198-204. [Abstract] Last accessed July 6, 2005.
  5. Lewis JH et al. Participation of patients 65 years of age or older in cancer clinical trials. Journal of Clinical Oncology 2003:231;1383-1389. [Abstract] Last accessed July 6, 2005.
  6. Townsley CA et al. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. Journal of Clinical Oncology 2005;23:3112-3124. [Abstract] Last accessed July 6, 2005.
  7. Tejeda HA et al. Representation of African-Americans [sic], Hispanics and whites in National Cancer Institute cancer treatment trials. Journal of the National Cancer Institute 1996;812-816. [Abstract] Last accessed February 1, 2006.
  8. Hesse B et al. Trust and sources of health information: The impact of the Internet and its implications for health care providers, findings from the first Health Information National Trends Survey. Archives of Internal Medicine 2005;165:2618-2624. [Abstract] Last accessed February 1, 2006.
  9. NCI Fact Book 2004. [Link to PDF] Last accessed July 5, 2005.
  10. Unger JM et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. Journal of Clinical Oncology 2006;24:1-4. [Abstract] Last accessed December 20, 2005.
  11. Goldman DP, et al. Incremental treatment costs in National Cancer Institute-sponsored clinical trials. Journal of the American Medical Association 2003;289:2970-2977. [Abstract] Last accessed September 12, 2005.
  12. Bennett CL et al. Clinical trials: are they a good buy? Journal of Clinical Oncology 2001;19:4330-4339. [Abstract] Last accessed September 12, 2005.
  13. Fireman BH et al. Cost of care for patients in cancer clinical trials. Journal of the National Cancer Institute 2000;92:136-142. [Abstract] Last accessed September 12, 2005.
  14. Wagner JL et al. Incremental costs of enrolling cancer patients in clinical trials: a population-based study. Journal of the National Cancer Institute 1999;91:847-853. [Abstract] Last accessed September 12, 2005.
  15. PhRMA home page Last accessed August 23, 2005.
  16. PhRMA 2005 Survey. [Link to PDF] Last accessed August 23, 2005.

< Previous Section


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov